MedPath

Evaluation of the effect of very high dose atorvastatin on candidates for elective angioplasty

Phase 3
Conditions
Acute myocardial infarction after elective stenting, contrast-induced nephropathy after elective stenting.
Atherosclerotic heart disease, Old myocardial infarction
I25.1, I25
Registration Number
IRCT2017011831073N2
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
340
Inclusion Criteria

candidate for Elective Percutaneous Coronary Intervention

Exclusion criteria: High-Sensitivity Cardiac Troponin more than 24 NG/ML; Creatinine Clearance less than 30; Liver function test more than 3 times greater than normal; Ejection fraction less than 30 percent; Consumption of Amiodarone, Calcium channel blockers, Colchicine, and Digoxin

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum high sensitive troponin T. Timepoint: Before and within 24 hours after PCI. Method of measurement: ELISA.;Urine NGAL. Timepoint: Before and 2 hours after PCI. Method of measurement: ELISA.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath